1-8 of 8
Ariela Arad
Close
Sort by
Journal Articles

The Utility of a Coagulation Laboratory Profile in Addition to Clinical Risk Factors for Thrombosis Risk Evaluation in Patients with Myeloproliferative Neoplasms: A Pilot Study

Inbal Shapira, Ela Shai, Yossef Kalish, Uria Tsubary, Shlomzion Aumann, Ariela Arad, Batia Roth Jelinek, Noa Buchman, Moshe E Gatt, Eran Zimran
Journal: Blood
Blood (2023) 142 (Supplement 1): 6401.
https://doi.org/10.1182/blood-2023-187136
Published: 2023
Journal Articles

A Novel Risk-Model to Predict Time to First Treatment (TTT) in Chronic Lymphocytic Leukemia Based on Heavy+Light Chain Immunoparesis and Serum Free Light Chain Analysis: Results from the Israeli CLL Study Group

Tamar Tadmor, MD, Andrei Braester, MD, Najib Dally, MD, Ariel Aviv, Yair Herishanu, MD, Mona Yuklea, MD, Lev Shvidel, MD, Naomi Rahimi-Levene, MD, Rosa Ruchlemer, MD, Ariela Arad, MD, Claudia Fogl, MD, Aaron Polliack, MD, Lee Magal, PhD, Kelly Townsend, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1849.
https://doi.org/10.1182/blood-2018-99-113771
Published: 2018
Journal Articles

Early Bone Marrow Examination, On The Fifth Day Of Induction For AML, Is Highly Predictive Of Response

Yishai Ofran, MD, Michal Hayun, PhD, Ronit Leiba, MSc., Tsila Zuckerman, MD, Netanel Horowitz, MD, Ron Hoffman, MD, Noam Benyamini, MD, Elinor Sabag, Adi Klil, MD, Alaa Khatib, MD, Noa Lavi, MD, Israel Henig, MD, Benjamin Brenner, MD, Moshe E. Gatt, MD, Ilana Hellmann, MD, Ariela Arad, MD, Shlomo Bulvik, MD, Sharon Gino-Moor, MD, Chezi Ganzel, MD, Revital Saban, MD, Ariella Tvito, MD, Jacob M. Rowe, MD
Journal: Blood
Blood (2013) 122 (21): 3893.
https://doi.org/10.1182/blood.V122.21.3893.3893
Published: 2013
Journal Articles

Richter’s Syndrome In Chronic Lymphocytic Leukemia: Clinical and Laboratory Features In 119 Patients, Attempting To Identify Possible Risk Factors

Tamar Tadmor, MD, Riva Fineman, MD, Lev Shvidel, Osnat Bairey, MD, Neta Goldschmidt, MD, Rosa Ruchlemer, Naomi Rahimi Rachimi, MD, Yair Herishanu, MD, Mona Yuklea, MD,, Ariela Arad, MD, Ariel Aviv, MD, Aaron Polliack, MD
Journal: Blood
Blood (2013) 122 (21): 5281.
https://doi.org/10.1182/blood.V122.21.5281.5281
Published: 2013
Journal Articles

Predictive Parameters for Infections During Azacitidine Therapy in High Risk MDS Patients,

Drorit Merkel, MD, Kalman Filanovsky, MD, Ariel Aviv, MD, Moshe E. Gatt, MD, Yair Herishanu, MD, Ariela Arad, MD, Tamar Tadmor, MD, Najib Dally, MD, Aharon Ronson, MD, Luiza Akria, MD, Andrei Braester, MD, Arnon Nagler, MD, Ronit Leiba, MSc., Yishai Ofran, MD
Journal: Blood
Blood (2011) 118 (21): 3811.
https://doi.org/10.1182/blood.V118.21.3811.3811
Published: 2011
Journal Articles

β 2 -glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model

Ariela Arad, Valerie Proulle, Richard A. Furie, Barbara C. Furie, Bruce Furie
Journal: Blood
Blood (2011) 117 (12): 3453–3459.
https://doi.org/10.1182/blood-2010-08-300715
Published: 2011
Journal Articles

Affinity-Purified Anti-Beta-2 Glycoprotein-1 Antibodies from a Patient with Lupus Anticoagulant-Associated Thrombosis Amplify Thrombus Formation in the Living Mouse.

Ariela Arad, Richard A Furie, Barbara C Furie, Bruce Furie
Journal: Blood
Blood (2009) 114 (22): 146.
https://doi.org/10.1182/blood.V114.22.146.146
Published: 2009
Journal Articles

Upregulation of Human Pim-2 in B-CLL, Involves Interactions between Oct-1, Oct-2, Bob-1 and NF-kB.

Yosef Dicken, BsC, Amos M. Cohen, M.D., Hanna Bessler, PhD, Daphna Levi-Hirsh, MsC, Ariela Arad, M.D., Drorit Merkel, M.D., Jeremy Don, PhD
Journal: Blood
Blood (2004) 104 (11): 1916.
https://doi.org/10.1182/blood.V104.11.1916.1916
Published: 2004